Shinobu Kobayashi

Shinobu Kobayashi

Auto-generated profile, based on publicly available information

Shinobu Kobayashi

Department of Social Medicine, National Center for Child Health and Development

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2019 in JMIR Research Protocols
Verified
Journal Article
Open access
KHKeiko Hikino
Keiko Hikino
SKShinobu Kobayashi
Shinobu Kobayashi
EOErika Ota
Erika Ota
TMTaisei Mushiroda
Taisei Mushiroda
TKTohru Kobayashi
Tohru Kobayashi
Background: Albuterol is one of the most frequently used medications in clinical practice and seeing varying responses to albuterol between individuals is not uncommon. Multiple studies have been conducted to investigate the associations of differing responses due to albuterol, particularly with regards to the two nonsynonymous single nucleotide polymorphisms (SNPs) at positions 16 (Arg16Gly: substitution of arginine to glycine at position 16; rs1042713) and 27 (Glu27Gln: substitution of glutamic acid to glutamine at position 27; rs1042714) on the β-2 adrenergic receptor (ADRB2) gene. However, the directions of the correlations are conflicting. Objective: The objective of this systematic review and meta-analysis is to assess the effect of the two SNPs on the ADRB2 gene, in terms of the responses that present in asthmatic patients shortly after albuterol inhalation. Methods: The primary outcome of this work is a detailed study of the associations of the two SNPs in the ADRB2 gene with treatment response and lung function testing shortly after administration of albuterol to asthmatic patients. A comprehensive literature search, using the OVID platform, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials, will be conducted by a specialized librarian without language restrictions. We will include both prospective and retrospective original observational studies, and we will exclude nonhuman or in vitro studies. All abstracts will be reviewed by two authors who will also individually perform data extraction from each eligible study. Any arising disagreements will be resolved through discussion with a third party. Risk of bias for all included studies will be independently assessed using the quality of genetic association studies tool. We will report the systematic review and meta-analysis, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. A narrative synthesis of study results or meta-analyses will be undertaken when appropriate. Results: At the moment of writing, we have already started the preliminary literature search and piloting of the study selection process. The anticipated completion date is September 30, 2019. Conclusions: Our systematic review and meta-analysis aims to clarify the current evidence of associations between the two nonsynonymous SNPs in the ADRB2 gene and the responses that present in asthmatic patients shortly after albuterol inhalation. If positive correlations are found, this knowledge may be used to improve personalized pharmacotherapy of albuterol use. Trial Registration: PROSPERO CRD42019074554; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=74554 International Registered Report Identifier (IRRID): PRR1-10.2196/14759

21 August 2018 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
EUErika Uehara
Erika Uehara
CNChie Nagata
Chie Nagata
HMHiroshi Masuda
Hiroshi Masuda
KFKentaro Fujimori
Kentaro Fujimori
SKShinobu Kobayashi
Shinobu Kobayashi
AIAkira Ishiguro
Akira Ishiguro

1 January 2025 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SKShinobu Kobayashi
Shinobu Kobayashi
SIShiori Itoi
Shiori Itoi
DSDrishti Shrestha
Drishti Shrestha
NMNaho Morisaki
Naho Morisaki
Background: Pre-pregnancy underweight (BMI<18.5 kg/m2) is notably prevalent among reproductive-aged Japanese women, affecting approximately 20%, compared to less than 10% in Western countries. However, its overall impact on maternal and infant outcomes in Japanese populations has not been systematically evaluated.Methods: We conducted a systematic review and meta-analysis following PRISMA 2020 guidelines. MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Library, and Ichushi were searched from inception to February 2024. Cohort and case-control studies examining associations between pre-pregnancy underweight and perinatal outcomes in Japanese women with singleton pregnancies were included. Primary outcomes were low birth weight (LBW), small for gestational age (SGA), and preterm birth (PTB). Random-effects models calculated pooled odds ratios (ORs) with 95% confidence intervals (CIs).Results: Thirty-four studies were analyzed. Pre-pregnancy underweight significantly increased risks of LBW (OR=1.61, 95% CI: 1.38-1.86), SGA (OR=1.59, 95% CI: 1.55-1.63), and PTB (OR=1.23, 95% CI: 1.19-1.26). Mean birth weight was 115.02g lower (95% CI: -128.05 to -101.99) in underweight mothers.Conclusions: Pre-pregnancy underweight among Japanese women is significantly associated with increased risks of adverse perinatal outcomes. Notably, these elevated risks persist despite the high background prevalence of underweight, suggesting that their adverse effects are not diminished in populations where it is more common. These findings underscore the importance of increasing awareness of preconception care and emphasize the need to optimize pre-pregnancy weight.

1 June 2000 in Vibrational Spectroscopy
Verified
Journal Article
Closed access
MTMamoru Takasuka
Mamoru Takasuka
SKShinobu Kobayashi
Shinobu Kobayashi
AIAkira Ino
Akira Ino
TITatsuo Iwata
Tatsuo Iwata
YHYoshio Hayase
Yoshio Hayase

1 January 2025 in Pediatrics International
Verified
Journal Article
Closed access
KFKenji Furuno
Kenji Furuno
ESEisuke Suganuma
Eisuke Suganuma
HMHiroshi Masuda
Hiroshi Masuda
ZKZenpei Kano
Zenpei Kano
JSJumpei Saito
Jumpei Saito
TKTohru Kobayashi
Tohru Kobayashi

1 January 2026 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SKShinobu Kobayashi
Shinobu Kobayashi
MSMaiko Suto
Maiko Suto
YNYosikazu Nakamura
Yosikazu Nakamura
HMHiroya Masuda
Hiroya Masuda
KKKoki Kosami
Koki Kosami
TKTohru Kobayashi
Tohru Kobayashi
Background: Kawasaki disease (KD) is a vasculitis syndrome of unknown etiology and the leading cause of acquired heart disease in children in developed countries. The Japanese Nationwide Survey of Kawasaki Disease (JNSKD) in Japan has provided valuable epidemiological data since 1970, but has inherent limitations. We aimed to evaluate the utility of the National Database of Health Insurance Claims (NDB) for describing the epidemiologic features of KD.Methods: We conducted retrospective cohort study compared NDB data (2013-2019) against JNSKD data for the same period. We analyzed demographic characteristics, temporal and geographic distributions, treatment modalities, and cardiac complications.Results: NDB identified 120,391 KD patients (2013-2019), with JNSKD estimated to cover 94.0% of cases. Demographic characteristics showed strong concordance between datasets (male-to-female ratios: 1.32 vs 1.33; similar age distributions). Initial IVIG administration rates were highly similar (93.74% vs 93.85%). Incomplete KD was significantly underestimated in NDB (8.07% vs 19.48%). NDB revealed adjunctive therapies including urinastatin and tracked increasing infliximab use. Cardiac complication detection in NDB showed limited sensitivity for mild abnormalities (overall 5.0% vs 7.33%). NDB showed higher recorded rates of giant aneurysms (0.53% vs 0.17%) and myocardial infarction (0.15% vs 0.01%).Conclusions: The NDB provides a valid, complementary data source for KD epidemiological research with near-complete population coverage. While limitations exist for identifying disease subtypes and cardiac complications, its detailed treatment data offer significant advantages for nationwide surveillance and health policy development.